{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:09:15Z","timestamp":1794964155627,"version":"4.9.1"},"reference-count":48,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2020,3,30]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Sickle cell disease (SCD) is a multisystem disease characterised by vaso-occlusive crisis, chronic anaemia and a shorter lifespan. More patients with SCD are living till reproductive age and contemplating pregnancy. Pulmonary complications in pregnancy are significant causes of maternal morbidity and mortality but yet this has not been systematically quantified. A systematic review and meta-analysis were conducted to quantify the association between SCD and pulmonary complications in pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>MEDLINE, EMBASE, Web of Science, Cochrane and Maternity and Infant Care databases were searched for publications between January 1998 and April 2019. Observational studies involving at least 30 participants were included. Random-effects models were used for statistical meta-analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>Twenty-two studies were included in the systematic review and 18 in the quantitative analysis. The meta-analysis included 3964 pregnancies with SCD and 336 559 controls. Compared with women without SCD, pregnancies complicated by SCD were at increased risk of pulmonary thromboembolism (relative risk (RR) 7.74; 95% CI 4.65 to 12.89). The estimated prevalence of acute chest syndrome and pneumonia was 6.46% (95% CI 4.66% to 8.25%), with no significant difference between the HbSS and HbSC genotypes (RR 1.42; 95% CI 0.90 to 2.23).<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>This meta-analysis highlighted a strong association between SCD and maternal pulmonary complications. Understanding the risks of and the factors associated with pulmonary complications would aid preconceptual counselling and optimal management of the condition in pregnancy, thereby reducing associated maternal morbidity and mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>PROSPERO registration number<\/jats:title><jats:p>CRD42019124708.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thoraxjnl-2019-213796","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T21:25:27Z","timestamp":1588109127000},"page":"568-575","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Pulmonary complications for women with sickle cell disease in pregnancy: systematic review and meta-analysis"],"prefix":"10.1136","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8867-2909","authenticated-orcid":false,"given":"Sivarajini","family":"Inparaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2903-0417","authenticated-orcid":false,"given":"Mickey","family":"Buckingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4697-4316","authenticated-orcid":false,"given":"Laura","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7904-7933","authenticated-orcid":false,"given":"Paul T","family":"Seed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Oteng-Ntim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"2024092103400624000_75.7.568.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7079.492"},{"key":"2024092103400624000_75.7.568.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2011.10.001"},{"key":"2024092103400624000_75.7.568.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303"},{"key":"2024092103400624000_75.7.568.4","article-title":"Evaluation of newborn sickle cell screening programme in England: 2010-2016","volume":"103","author":"Streetly","year":"2018","journal-title":"Arch Dis Child"},{"key":"2024092103400624000_75.7.568.5","unstructured":"Royal College of obstetricians and gynaecologists (2011) management of sickle cell disease in pregnancy, 2019. Available: https:\/\/www.researchgate.net\/publication\/263052981_Royal_College_of_Obstetricians_and_Gynaecologists_guidelines_How_evidence-based_are_they [Accessed 27 Jun 2019]."},{"key":"2024092103400624000_75.7.568.6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.aoa.0000511999.06517.f5","article-title":"Pregnancy outcomes in women with sickle-cell disease in low and high income countries","volume":"37","author":"Boafor","year":"2017","journal-title":"Obstetric Anesthesia Digest"},{"key":"2024092103400624000_75.7.568.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-607317"},{"key":"2024092103400624000_75.7.568.8","unstructured":"Guidelines on autopsy practice: autopsy in sickle cell disease and persons with sickle cell trait, 2017. Available: https:\/\/www.rcpath.org\/uploads\/assets\/27824659-5adc-4641-9824e08d6980443f\/guidelines-on-autopsy-practice-autopsy-in-sickle-cell-disease-and-sickle-trait-persons.pdf [Accessed 20 Jun 2019]."},{"key":"2024092103400624000_75.7.568.9","doi-asserted-by":"publisher","DOI":"10.1159\/000350283"},{"key":"2024092103400624000_75.7.568.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"2024092103400624000_75.7.568.11","unstructured":"Wells G , Shea B , O\u2019Connell D , et al . The Newcastle-Ottawa scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. Available: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"2024092103400624000_75.7.568.12","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"2024092103400624000_75.7.568.13","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"2024092103400624000_75.7.568.14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/03630269.2013.780249","article-title":"Maternal complications and the association with baseline variables in pregnant women with sickle cell disease","volume":"37","author":"Al-Farsi","year":"2013","journal-title":"Hemoglobin"},{"key":"2024092103400624000_75.7.568.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-009-1002-7"},{"key":"2024092103400624000_75.7.568.16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.12816\/0047381","article-title":"Pregnancy outcome of sickle cell disease women","volume":"38","author":"Al-Jufairi","year":"2016","journal-title":"Bahrain Medical Bulletin"},{"key":"2024092103400624000_75.7.568.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2012.07.008"},{"key":"2024092103400624000_75.7.568.18","doi-asserted-by":"crossref","first-page":"E167","DOI":"10.1002\/ajh.25115","article-title":"A case series describing causes of death in pregnant women with sickle cell disease in a low-resource setting","volume":"93","author":"Asare","year":"2018","journal-title":"Am J Hematol"},{"key":"2024092103400624000_75.7.568.19","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-012-1216-3"},{"key":"2024092103400624000_75.7.568.20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bjhh.2014.05.007","article-title":"Clinical complications in pregnant women with sickle cell disease: prospective study of factors predicting maternal death or near miss","volume":"36","author":"Resende Cardoso","year":"2014","journal-title":"Rev Bras Hematol Hemoter"},{"key":"2024092103400624000_75.7.568.21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.14423\/SMJ.0000000000000900","article-title":"Maternal\/Perinatal outcome in women with sickle cell disease: a comparison of two time periods","volume":"111","author":"Chang","year":"2018","journal-title":"South Med J"},{"key":"2024092103400624000_75.7.568.22","doi-asserted-by":"publisher","DOI":"10.3109\/03630269.2013.828301"},{"key":"2024092103400624000_75.7.568.23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9069054","article-title":"Pregnancy in sickle cell disease is a very high-risk situation: an observational study","volume":"2016","author":"Elenga","year":"2016","journal-title":"Obstet Gynecol Int"},{"key":"2024092103400624000_75.7.568.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2010.05.022"},{"key":"2024092103400624000_75.7.568.25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/1117-1936.177482","article-title":"Pregnancy outcome in women with sickle cell - a five year review","volume":"14","author":"Omo-Aghoja","year":"2007","journal-title":"Niger Postgrad Med J"},{"key":"2024092103400624000_75.7.568.26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/bjh.13270","article-title":"Pregnancy outcome in patients with sickle cell disease in the UK--a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease","volume":"169","author":"Oteng-Ntim","year":"2015","journal-title":"Br J Haematol"},{"key":"2024092103400624000_75.7.568.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2006.02.007"},{"key":"2024092103400624000_75.7.568.28","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.thromres.2014.09.037","article-title":"Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysis","volume":"134","author":"Seaman","year":"2014","journal-title":"Thromb Res"},{"key":"2024092103400624000_75.7.568.29","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000127433.23611.54"},{"key":"2024092103400624000_75.7.568.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2005.00678.x"},{"key":"2024092103400624000_75.7.568.31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bjhh.2014.07.002","article-title":"Sickle cell disease and pregnancy: analysis of 34 patients followed at the regional blood center of Ribeir\u00e3o Preto, Brazil","volume":"36","author":"Silva-Pinto","year":"2014","journal-title":"Rev Bras Hematol Hemoter"},{"key":"2024092103400624000_75.7.568.32","doi-asserted-by":"publisher","DOI":"10.1177\/1753495X16651529"},{"key":"2024092103400624000_75.7.568.33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.10.354","article-title":"Morbidity associated with sickle cell disease in pregnancy","volume":"195","author":"Villers","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"2024092103400624000_75.7.568.34","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2012.11-0625"},{"key":"2024092103400624000_75.7.568.35","doi-asserted-by":"publisher","DOI":"10.1080\/01443610903003175"},{"key":"2024092103400624000_75.7.568.36","unstructured":"British Society for haematology . Management of acute chest syndrome in sickle cell disease, 2020. Available: https:\/\/b-s-h.org.uk\/guidelines\/guidelines\/management-of-acute-chest-syndrome-in-sickle-cell-disease\/ [Accessed 8 Mar 2020]."},{"key":"2024092103400624000_75.7.568.37","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25643","article-title":"Third trimester and early postpartum period of pregnancy have the greatest risk for ACS in women with SCD","volume":"94","author":"Asare","year":"2019","journal-title":"Am J Hematol"},{"key":"2024092103400624000_75.7.568.38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-649319"},{"key":"2024092103400624000_75.7.568.39","first-page":"CD010378","article-title":"Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy","volume":"12","author":"Okusanya","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2024092103400624000_75.7.568.40","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ajh.24790","article-title":"Implementation of multidisciplinary care reduces maternal mortality in women with sickle cell disease living in low-resource setting","volume":"92","author":"Asare","year":"2017","journal-title":"Am J Hematol"},{"key":"2024092103400624000_75.7.568.41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.25356","article-title":"Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting","volume":"94","author":"Oppong","year":"2019","journal-title":"Am J Hematol"},{"key":"2024092103400624000_75.7.568.42","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V84.2.643.643","article-title":"The acute chest syndrome in sickle cell disease: incidence and risk factors. the cooperative study of sickle cell disease","volume":"84","author":"Castro","year":"1994","journal-title":"Blood"},{"key":"2024092103400624000_75.7.568.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804411"},{"key":"2024092103400624000_75.7.568.44","unstructured":"RCOG guideline on reducing the risk of VTe during pregnancy and the puerperium, 2019. Available: https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/gtg-37a.pdf [Accessed 20 Jun 2019]."},{"key":"2024092103400624000_75.7.568.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00162-4"},{"key":"2024092103400624000_75.7.568.46","doi-asserted-by":"crossref","DOI":"10.1007\/s11936-017-0565-z","article-title":"Preconception counseling for women with cardiac disease","volume":"19","author":"Clapp","year":"2017","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"2024092103400624000_75.7.568.47","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.095240"},{"key":"2024092103400624000_75.7.568.48","unstructured":"Lewis G . The Confidential Enquiry into Maternal and Child Health, 2000\u201302 (Why Mothers Die), 2003\u201305 (Saving Mothers\u2019 Lives). Reports on Confidential Enquiries into Maternal Deaths in the United Kingdom. 2004. London: CEMACH, 2007."}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2019-213796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T10:41:33Z","timestamp":1726915293000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2019-213796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,6,26]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/thoraxjnl-2019-213796"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2019-213796","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]}}}